Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Submitted by
admin
on June 11, 2017 - 4:58pm
Source:
Endpoints
News Tags:
Eli Lilly
migraines
galcanezumab
Headline:
Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Do Not Allow Advertisers to Use My Personal information